Analysis of Natural Products and Pharmaceuticals
A section of Separations (ISSN 2297-8739).
Section Information
We are pleased to introduce a new Section of Separations under the topic “Analysis of Natural Products and Pharmaceuticals”
In general terms, “Natural Products” can be defined as all compounds that are synthesized/produced by living organisms (plants, animals, etc.). The importance of Natural Products has been recognized for thousands of years and, still today, a considerable fraction of new drugs is based on the discovery of natural biogenic molecules.
In the Section “Analysis of Natural Products and Pharmaceuticals”, we are welcoming original research and review articles on the development and application of analytical methods in both natural product and pharmaceuticals science.
Research on the analysis of Natural Products should ideally increase the current knowledge on the extraction, isolation, identification, structure elucidation and quantification of bioactive compounds. All aspects of instrumental analysis that can be used as a tool to achieve these tasks are welcome. Reports on Quality Control and Standardization of Natural Products will also be considered on the basis of their significance in the field.
Analysis of Pharmaceuticals, on the other hand, is an extremely broad topic ranging from quality control or raw materials to impurity profiling of active ingredients and to bioanalytical applications. Original work on all aspects of related research is welcome. Impurity profiling and especially identification/quantification of genotoxic impurities are of particular interest, while simple assays using HPLC should provide clear advantages from an analytical point of view in order to be processed further. Research work from industries reporting the results from real-world analytical problems is also welcome. All pharmaceutical-related analytical methods should be fully validated.
Bioanalytical methods including pharmacokinetic, bioequivalence, protein and DNA binding studies are welcome on the basis of analytical novelty, including sample preparation. Real-world applications (endogenous analytes or sampling from patients) are highly recommended versus demonstration through spiking of blank biological matrices.
In all cases, novelty will be the major suitability criterion of submitted articles. Authors must, therefore, always address the question of how their proposed methodology compares with previously reported methods.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Isolation of Natural Compounds—Emphasis on Antioxidants' Purification (Deadline: 20 December 2024)
- Extraction and Characterization of Bioactive Compounds from Plant and Natural Sources (Deadline: 31 December 2024)
- The 10th Anniversary of Separations: Advances in Separation and Analysis of Natural Products/Medicines (Deadline: 31 December 2024)
- Advanced Research on Extraction and Analysis of Plant Extracts (Deadline: 10 February 2025)
- Green Extraction Techniques of Bioactive Compounds from Natural Sources (Deadline: 20 February 2025)
- Research Progress for Isolation of Plant Active Compounds (Deadline: 10 March 2025)
- Separation Techniques in Drug Analysis (Deadline: 20 April 2025)
- Isolation and Identification of Biologically Active Natural Compounds (Deadline: 10 May 2025)
- Green Extraction Processes to Recover Natural Bioactive Compounds from Food By-Products (Deadline: 10 May 2025)
- Novel Green Solvents for the Separation and Purification of Valuable Natural Ingredients (Deadline: 20 June 2025)
- Green Extraction Techniques for Bioactive Products from Natural Sources (Deadline: 20 July 2025)
Topical Collection
Following topical collection within this section is currently open for submissions: